Background-Supervised walking programs offered at medical facilities for patients with peripheral artery disease (PAD) and intermittent claudication (IC), while effective, are often not utilized due to barriers including lack of reimbursement and the need to travel to specialized locations for the training intervention. Walking programs for PAD patients that occur in community settings, such as those outside of supervised settings, may be a viable treatment option, as they are convenient and potentially bypass the need for supervised walking. This review evaluated the various methodologies and outcomes of community walking programs for PAD.
Introduction
Atherosclerotic peripheral artery disease (PAD) results from the accumulation of plaque in the arteries of the periphery and causes intermittent claudication (IC) in approximately onethird of patients. 1 A comprehensive medical approach to reducing cardiovascular risk is warranted in all PAD patients. In addition, those with IC should receive therapy focused on improving walking ability, functional capacity and patient-reported outcomes. Supervised walking exercise is an effective therapy for treating PAD and is regarded as the gold standard therapy for improving outcomes. These programs are associated with a number of implementation barriers however, such as lack of reimbursement and the high volume of exercise visits at clinical settings required of patients over an extended period of time. Walking programs that occur in community settings (those programs outside of supervised hospital and clinical settings) have recently gained attention in the vascular medicine literature as they potentially bypass many of the barriers associated with supervised walking programs. However, given that community walking programs have largely been ineffective for PAD patients, a discussion of the various methods employed and relevant outcomes assessed following walking interventions may help reveal why this type of therapy has been ineffective. Thus the purpose of this review was to summarize the methods and results of community walking programs for PAD patients with IC.
Relevant outcomes for PAD
Treadmill walking is a primary objective modality to assess a PAD patient's walking ability and is considered reliable and valid for those with IC. 2, 3 The most commonly assessed treadmill outcomes include measures of claudication onset time (COT) or distance walked to claudication onset and peak walking time (PWT) or maximal walking distance. 4, 5 Typically COT and PWT are assessed using a graded treadmill protocol, 6 but constant load treadmill testing 6, 7 is also an accepted method used to assess walking distance. Functional ability of PAD patients relates to their physical ability to perform sustained ambulation at home or in the community as well as the ability to perform activities that involve the lower limbs (e.g., moving from a seated to standing position). This is an important outcome to evaluate as PAD patients demonstrate a greater functional decline over time compared to those without PAD. 8 Objective measures such as the 6 minute walk test as well as balance and short distance shuttle tests (walking a defined distance back and forth signaled by a timer) have been used to assess functional ability. 9-13 The 6 minute walk test (walking a pre-defined course for a specified time and recording the distance achieved) is perhaps the best and most valid physical function test for PAD and IC. [11] [12] [13] Several trials have demonstrated that meters walked over the 6 minutes increase significantly following exercise interventions for PAD. [14] [15] [16] This is an important outcome as the 6 minute walk test is strongly related to mortality rates, mobility and overall physical function during daily life in PAD patients. 12, 17 Thus, functional outcomes provide clinicians with additional objective information for evaluating the progress of the patient following a therapeutic intervention, given that these tests reflect the patient's walking ability from a practical standpoint.
Patient-reported outcomes, defined as patient's perceived physical, emotional, and social well-being and function, are also important to assess as patient perception of a treatment's impact on their health may aid a clinician in determining the appropriate therapy for PAD. 18 A number of validated general and PAD-specific tools exist for measuring patient-reported outcomes following exercise training programs, the most commonly used being the Medical 
Supervised walking exercise: Cornerstone of PAD Therapy
There are a number of supervised exercise modalities such as leg and arm ergometry, polestriding and strength training that have been used to treat PAD and IC in supervised clinical exercise settings. 26 However, the primary validated exercise therapy for patients with PAD and IC is a program of hospital-based supervised walking. 27, 28 This therapy is recommended as an initial treatment for IC prior to any endovascular or open revascularization and is classified IA by the ACC/AHA PAD practice guidelines. 27 This rating is given because of the pronounced improvement in walking ability of PAD patients with IC following the therapy as demonstrated in multiple randomized clinical trials. [29] [30] [31] [32] Supervised walking exercise has also been cited in trials to be a beneficial treatment following endovascular or surgical procedures, providing additional evidence of its benefit for PAD patients. 33, 34 Effects of supervised walking for PAD patients Supervised walking programs consist primarily of treadmill walking exercise and include brief periods of rest when moderate leg pain occurs. 32 Supervised walking exercise has been studied extensively and results of most randomized clinical trials indicate that overall walking ability of PAD patients is improved by this therapy. 29, 30, 35, 36 Additionally, a Cochrane database systematic review of randomized controlled trials conducted by Watson et al 37 found that PWT (or maximal meters walked) as well as COT (or distance to claudication onset) are significantly improved following exercise training compared to the standard of care or placebo for PAD patients with IC. 37 Briefly, in a sample of 255 PAD patients in 7 total studies, the Cochrane review found a PWT mean difference of 5.12 minutes between supervised walking compared to standard of care and placebo groups. 37 Similar results were demonstrated for 391 PAD patients in 6 total studies, where a mean difference of 113.2 meters was found between supervised walking and standard of care or placebo groups (p<.001). The COT was also improved for patients in the supervised walking vs standard of care or placebo groups in 9 total studies analyzed.
The exact physiological changes leading to the improvement of walking ability in PAD patients remain unclear. Several PAD studies have reported that the benefit obtained from walking exercise may be due to an improvement in skeletal muscle adaptation and metabolism as well as the oxidative capacity of the active muscles. 38, 39 A number of studies have shown that exercise rehabilitation for IC does not improve blood flow to the leg 40, 41 although several studies have reported modest improvements. 30, 42 Other possible mechanisms for the improvement in walking ability include an improvement in walking economy (rate of oxygen consumption in relation to distance completed), 43,44 increased angiogenesis, 45 a decrease in blood viscosity, 46 improvement in endothelial function, 47 a decrease in atherosclerosis and an increase in pain tolerance. 30 
Supervised walking exercise prescription
The standardized nature of the supervised walking program design has been highlighted as one of its strengths. 1 Supervised exercise training is effective in part because of a prescribed exercise intensity, frequency and duration that induce a training response in PAD patients with IC. Typically, the walking program lasts for a minimum of 30 to 45 minutes each session, for at least 3 sessions per week and a minimum of 3 months. 27 Regarding exercise intensity, walking to moderate (not mild or severe) levels of pain on a treadmill before resting is prescribed most commonly and is also recommended by the ACC/AHA PAD practice guidelines. 27 Thus the patient walks until the onset of moderate leg pain, rests until the pain has subsided and then resumes walking again. It is important to note that PAD patients may experience a familiarization effect during repeated exercise testing and/or training on a treadmill not solely related to a walking intervention. 5 Clinicians and researchers should be aware of this when establishing the efficacy of the walking program or performing repeated exercise tests, as the familiarization with the treadmill may be due to a biomechanical improvements in walking as patients become familiar with the treadmill, which has been cited to be as high as 100% improvement over just several weeks. 5 The role of the different exercise prescription components (e.g., frequency, duration of exercise and intensity of walking) and assessing which contributes most to the training response is unclear. A recent systematic review of 25 randomized clinical trials evaluated the impact of individual supervised walking exercise prescription components on maximal walking distance and distance to claudication onset in PAD patients using regression analyses. 48 Results indicated that none of the exercise prescription components were independently associated with a significant improvement in maximal walking distance for PAD patients. The authors did note that medium length programs (i.e., 12-26 weeks) were more likely to show improvement in walking outcomes as compared to short (<12 weeks) and long (>26 weeks) term exercise programs (maximal walking distance: +223 vs +123 vs +145 meters; distance to claudication onset: +146 vs +100 vs +109 meters). 48 This finding however conflicts with recent reports by Gardner et al 49 who determined that PWT and COT improve quickly during the first 2 months of supervised walking and then plateau, also implying that adherence to exercise is better with programs that are only 2 months in duration. Until more research in this area is conducted, the greatest improvements in walking ability of PAD patients consists of a comprehensive exercise prescription strategy using established exercise frequency, duration and intensity components, which has been the accepted practice over the last several decades. 32 
Supervised walking is effective but not feasible
Supervised walking exercise has been cited as cost-effective in terms of improving walking ability for patients with claudication. 50-56 Briefly, van Asselt et al 53 evaluated the costeffectiveness of supervised walking compared to unsupervised walking where only general walking advice was given. Findings indicated that the supervised walking program was more effective for improving maximal walking distance than the unsupervised walking program for PAD patients (620 vs 400 meters, p<.001) but was also more costly (3407 vs 2304 Euros) which may be a barrier to implementing supervised walking programs. In the US, there is a lack of insurance reimbursement for supervised walking programs, few available local training centers, and PAD patients are required to travel to available facilities several days per week for several months which may not be feasible. 57,58 Thus supervised walking programs are effective but the difficulty of implementing such programs provides a rationale for the use of walking programs in community settings, as they may be less costly and more feasible for patients to participate in. When considering the environment of the exercise sessions, many barriers associated with supervised walking programs may be bypassed when programs are conducted in community settings.
Methods
We reviewed PubMed/Medline and the Cochrane database to find studies that conducted community walking exercise programs for PAD patients with IC from 1990 to 2013. Because of the multiple study designs for walking programs in community settings for PAD, we included a broad combination of search terms to identify appropriate studies in the area.
Search terms included "community exercise," "home exercise," "unsupervised exercise," "physical activity," "walking," "peripheral artery disease," "peripheral arterial disease," "PAD," and "intermittent claudication." A large number of studies employed a treatment arm which only included general advice to walk. Therefore, we narrowed our search further to include only those studies that reported peak walking time (PWT) or maximal walking distance as the primary outcome. There were fewer studies identified that included more intensive exercise program components (e.g., monitoring, feedback) for community walking programs and PAD. Thus we included all studies in this area regardless of the design or study endpoints.
Results

Community walking programs
Walking programs in community settings for PAD patients can refer to any form of structured ambulation program completed outside a supervised clinical setting. Typically these programs originally consisted solely of advice to walk in the community (thus unsupervised) but more recent studies have provided innovative components and approaches to improve delivery and outcomes of PAD patients. The current recommendation and level of evidence for community walking programs (unsupervised) as reported in the ACC/AHA PAD practice guidelines for the management of patients with PAD is class IIb with an evidence level of B, 27 indicating that these programs are not well established as an effective treatment option. Findings from multiple trials of supervised exercise vs non-supervised exercise programs for patients with PAD and IC support the ACC/AHA ratings. Additionally, a Cochrane database systematic review examined walking outcomes following supervised exercise therapy vs non-supervised (home and community) exercise therapy for IC. 59 The authors reported that maximal walking distance was greater for supervised walking groups compared with the non-supervised groups following 3 month (n=236, 6 studies; overall effect size [magnitude of treatment effect]: 0.58, CI: 0.31 to 0.85, p<0.0001), 6 month (n=172, 5 studies; overall effect size: 0.89, CI: 0.57 to 1.21; p<0.0001) and 12 month (n=69, 2 studies; overall effect size: 1.01, CI: .50 to 1.52, p<.0001) outcome assessment time points.
Results of PAD community walking studies with advice only
Many of the community walking programs for PAD and IC to date have been conducted with advice to walk but with little further instruction, thus relying primarily on patient selfmonitoring. 30, 36, 57, [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] Regensteiner et al 36 randomly assigned PAD patients to a supervised, hospital-based walking program or an unsupervised walking program in the community setting for a 3-month intervention time period. Patients in the unsupervised community walking program were given detailed exercise instructions during the initial hospital visit followed by a weekly phone call but did not receive any direct training. The main finding was that patients randomized to the supervised walking program improved treadmill exercise performance (PWT: +137%; COT: +150%) more than the unsupervised walking program participants in the community setting (PWT: +5%; COT: +26%). Recently, Allen et al 69 examined walking outcomes of PWT and COT in 33 PAD patients with IC following a 3 month period. Patients were randomized to 1) supervised walking exercise in a hospital setting (intervention) or 2) unsupervised walking at home (control). The unsupervised home program consisted of advice to exercise daily by walking and patients were asked to keep notes of their exercise (also called every 3 weeks to answer exercise related questions patients had, if any). The supervised walking group improved both PWT and COT from baseline to 3 months (PWT: +260 seconds; COT: +138 seconds) while the unsupervised home walking group did not significantly improve either walking outcome from baseline to 3 months (PWT: +93 seconds; COT: +77 seconds). Table I provides a review of randomized controlled PAD exercise trials using the community as the setting for walking where primarily exercise advice was given. Eleven studies including a total of n=595 PAD patients (sample size range n=19 to n=252) were identified that evaluated walking outcomes of PWT or maximal walking distance as well as COT or distance to claudication onset. Four of the 11 studies reported PWT as the primary walking outcome while the other 7 studies evaluated maximal walking distance. Results overall supported that supervised exercise improved walking more than home programs. Many of these programs used the community walking groups as the control arm (standard of care), given that many patients with PAD have not habitually exercised and often the primary aims were to establish the effectiveness of supervised walking exercise. Most of these programs have not yielded significant improvement in walking ability.
New perspectives for PAD walking programs in community settings
More recently, programs are being developed using established supervised walking exercise guidelines that more intensively train and monitor PAD patients over the course of an intervention and provide direct feedback on how to improve walking ability. In contrast to supervised walking exercise programs, less is known about the optimal prescription for PAD patients walking in the community given that barriers and facilitators to exercise are different between settings. Because supervised exercise training is efficacious, modeling the community program on some elements of the supervised program may be beneficial. However, a limiting factor of community walking program implementation is that the guidelines for supervised exercise training overall may not be feasibly applied in the typical community setting. For example, when a patient experiences IC in the community while walking, they may stand in place rather than sitting as there may not be adequate seating available. Thus, patients with PAD have cited the need to take rest breaks as a key barrier and that availability of seating for rest facilitates walking in community settings. 70 An additional impedance to walking exercise in community settings (outdoors specifically) that has been cited by PAD patients in focus groups is the quality of sidewalks. Uneven or icy sidewalks were discouraging to patients and led to decreased ambulation. Environmental factors relating to low quality walking surfaces have also been cited as a precipitating factor for falls among middle aged and older adults, with 73% of falls directly resulting from uneven sidewalk surfaces and due to objects such as curbs. 71 Thus the walking environment could potential present numerous barriers to implementing effective walking programs in community settings for PAD patients with barriers varying for each individual and highly specific to their disease-related impairments. [72] [73] [74] Given this constraint, it may be important that interventions based in the community include an evaluation of objective features of the local walking environment to help PAD patients develop a tailored walking plan to improve adoption and adherence to exercise in the community setting. The question of how the elements of supervised exercise programs can be implemented into the community setting is critically important and requires additional attention for these programs to be successful. Thus the failure of community exercise training studies that have only provided advice to walk at home, demonstrates the lack of acknowledgment of the multifaceted social and environmental landscape that is associated with community walking. While it has been previously understood that exercise programs should ideally incorporate a sufficient level of intensity, duration and frequency to be effective, 32 recent evidence indicates prescription components such as low intensity exercise may be just as beneficial as high intensity walking. [75] [76] [77] This is important to acknowledge as PAD patients are generally sedentary 78 and may not be aware of the appropriate exercise regimen required to improve their walking ability (thus non-compliant at higher levels of walking intensity). Another factor that is important, is that a program of exercise training initially may provide the knowledge and skills necessary to increase a patient's propensity to walk. However, if travel to clinical settings for supervised walking is not feasible even for a short period of time (1-2 weeks), community locations may need to be selected to adequately train PAD patients on how to walk effectively.
Results of recent approaches to PAD community walking programs
Recent community walking studies have provided clinicians and researchers further direction on how to successfully utilize supervised walking program components in an effort to translate the success of supervised programs to community settings. 44, 56, [79] [80] [81] [82] [83] [84] Evidence suggests that this type of intervention yields better results than studies where little or no instruction is given to patients with regard to exercise. Gardner et al 44 randomized 119 patients with IC into a supervised walking program, a walking program in the community setting, and a non-exercising control group. Patients in the walking groups were 1) provided activity monitors, 2) received seven, 15 min sessions where patients discussed their progress with an exercise physiologist, 3) were given feedback about the data from the activity monitor and 4) were given new instructions on changes in exercise duration. Differences were found between both exercise groups vs the control group for walking outcomes of PWT and COT (supervised walking: PWT +215 and COT +165 seconds; community walking: PWT +124 and COT +134 seconds; control group: PWT −10 and COT −16 seconds, p<.05). 44 A multi-center, randomized control trial conducted by Hiatt et al 85 found that the inclusion of supervised walking at set intervals in addition to using an activity monitor and exercise log book during a 6 month community walking program was beneficial for PAD patients, as the authors concluded that exercise was as effective for improving walking outcomes and patient-reported outcomes (via the WIQ and SF-36) compared to exercise in combination with the medication propionyl-L-carnitine. Thus community programs with more intensive individual interventions modeled after supervised walking programs provide evidence of effectiveness for improving walking ability and patientreported outcomes.
Recently, McDermott et al 14 conducted a randomized, controlled walking trial for PAD patients with and without IC using a group-mediated cognitive behavioral walking intervention that included principles from social cognitive theory, group dynamics and the self-regulation knowledge base. Control patients attended weekly (60 min) health education group sessions as well as lectures for management of health (e.g., hypertension control, cancer screenings). Patients in the intervention group attended once per week group meetings for a total of 90 minutes, consisting of 45 minutes of education lectures and counseling (e.g., benefits of walking, self-monitoring) and 45 minutes of walking in a supervised setting at an indoor track. Patients were then instructed to walk to severe leg discomfort in the community (outside, over-ground rather than indoor treadmill walking) over the course of the 6 month intervention for a minimum of 5 days per week and up to 50 minutes each session. Results indicated that the primary outcome of change in 6-minute walk distance was significantly different for patients in the intervention group (+42.4, CI=27.9 to 56.8 meters) compared to patients in the control group (−11.4, CI=−25.4 to 3.2 meters, p < .001). Secondary outcomes of PWT and COT were also significantly different between intervention and control groups (+1.54 vs. +0.53 min, p=.04; +1.43 vs. +0.42 min, p=.02). Thus the use of appropriate training advice to walk in community settings, the inclusion of exercise supervision at pre-defined locations and implementation of exercise and health education for PAD patients in group settings may be beneficial for use in the development of comprehensive community-based walking programs. Table II provides a review of community walking trials that have provided more intensive programming for patients with PAD and IC. In total, 9 trials (n=823 PAD patients) were reviewed which included 3 studies that did not have a comparison group or were retrospective by design. Three trials evaluated PWT and COT and the other 6 trials examined maximal walking distance and distance to claudication onset in PAD patients following the exercise programs.
Not all studies have been successful for improving outcomes in PAD patients. Two of the nine studies demonstrated mixed results. 79, 83 In general however, the majority of these types of studies did report improvements in walking ability and questionnaire-based outcomes for PAD patients.
Conclusions
This review provides an overview of the benefits of walking exercise and a discussion of community walking programs to improve the health of PAD patients. Supervised walking exercise improves the walking ability, functional ability and patient-reported outcomes of PAD patients. However, because the current state of the healthcare system limits the supervised exercise treatment options for PAD patients in addition to other logistical barriers (e.g., transportation, proximity to clinics), it is clear that innovative community walking programs need to be developed. Community programs have potential to be successful as they are generally more convenient in terms of a patient's schedule, that is, patients are able to exercise at locations close to their homes and avoid potential barriers such as transportation to supervised exercise in clinics. It should be noted that inclusion of some elements of supervised training may be needed for exercise programs that primarily occur in community settings as a way of coaching PAD patients who have never exercised consistently. Thus future studies aimed at improving upon the "go home and walk" exercise advice strategy often provided to PAD patients should incorporate more intensive monitoring by staff as well as coaching patients to monitor their own exercise while in the community. Community walking programs for symptomatic PAD may be effective when a proper intervention is employed, as the characteristics of the intervention need to go beyond simple recommendations to exercise. The implications of successful programs include the improvement of PAD patients' walking ability, enhanced functional ability in community settings, an improved overall quality of life and a potential decrease in healthcare expenditures. 
